Nxera Pharma Co.,Ltd. 4565Short Interest
Estimated short interest in Nxera Pharma Co.,Ltd. (4565) is 7.35% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Linden Capital L.P., Nomura International plc, BNP Paribas Financial Markets SNC and 2 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 3 institutions whose last report is more than a year old (1.95% in total). It also excludes 20 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-30 |
|---|---|
| Latest disclosure | 2026-11-13 (BNP Paribas Financial Markets SNC, 1.44%) |
| Reporting institutions | 29 firms (3266 reports) |
| Peak estimated short interest | 12.19% (2023-12-08, 8 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Linden Capital L.P.
- Nomura International plc
- BNP Paribas Financial Markets SNC
- Citigroup Global Markets Limited
- UBS AG
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-10 | Linden Capital L.P. | Position 2,714,819 shares | Ratio 2.93% | ▲0.14% | Holding |
| 2026-11-12 | Nomura International plc | Position 1,341,571 shares | Ratio 1.44% | ▼0.10% | Holding |
| 2026-11-13 | BNP Paribas Financial Markets SNC | Position 1,340,100 shares | Ratio 1.44% | ▼0.20% | Holding |
| 2026-11-12 | Citigroup Global Markets Limited | Position 928,915 shares | Ratio 1.00% | ▲0.38% | Holding |
| 2017-11-02 | JPMorgan Securities Japan Co., Ltd. | Position 141,566 shares | Ratio 0.83% | ▲0.05% | No report for 1+ year |
| 2017-10-20 | Arrowstreet International Equity - Alpha Extension Fund | Position 103,900 shares | Ratio 0.61% | ▲0.11% | No report for 1+ year |
| 2026-11-13 | UBS AG | Position 506,056 shares | Ratio 0.54% | ▲0.23% | Holding |
| 2023-11-29 | BNP Paribas Arbitrage SNC | Position 420,900 shares | Ratio 0.51% | ▲0.51% | No report for 1+ year |
| 2025-07-02 | MERRILL LYNCH INTERNATIONAL | Position 451,374 shares | Ratio 0.49% | ▼0.07% | Below 0.5% |
| 2019-06-07 | Deutsche Bank Aktiengesellschaft, London | Position 380,600 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2018-05-16 | BlackRock Institutional Trust Company, N.A. | Position 93,400 shares | Ratio 0.49% | ▼0.22% | Below 0.5% |
| 2018-09-21 | Vinva Asia Pacific Equity Long-Short Fund | Position 371,500 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2021-08-27 | Credit Suisse AG | Position 405,211 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2022-03-16 | D. E. Shaw & Co. (Asia Pacific) Limited | Position 404,600 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2023-07-03 | Nomura Securities Co., Ltd. | Position 411,131 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2025-10-07 | Qube Research & Technologies Limited | Position 447,000 shares | Ratio 0.49% | ▼0.07% | Below 0.5% |
| 2026-01-05 | Arrowstreet Capital, Limited Partnership | Position 449,100 shares | Ratio 0.49% | ▼0.07% | Below 0.5% |
| 2024-05-07 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 432,668 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 419,913 shares | Ratio 0.45% | ▼0.05% | Below 0.5% |
| 2024-04-12 | Jefferies International Limited | Position 398,700 shares | Ratio 0.44% | ▼0.20% | Below 0.5% |
| 2026-10-22 | Morgan Stanley MUFG Securities Co., Ltd. | Position 399,575 shares | Ratio 0.43% | ▼0.09% | Below 0.5% |
| 2020-01-06 | AQR Capital Management, LLC | Position 338,500 shares | Ratio 0.43% | ▼0.15% | Below 0.5% |
| 2026-01-09 | JPM Securities Japan Co Ltd. | Position 393,053 shares | Ratio 0.43% | ▼0.15% | Below 0.5% |
| 2026-11-02 | GOLDMAN SACHS INTERNATIONAL | Position 300,946 shares | Ratio 0.32% | ▼0.38% | Below 0.5% |
| 2023-06-29 | Mizuho Securities Co., Ltd. | Position 206,611 shares | Ratio 0.25% | ▼0.46% | Below 0.5% |
| 2023-05-08 | JANE STREET GLOBAL TRADING, LLC | Position 92,698 shares | Ratio 0.11% | ▼0.88% | Below 0.5% |
| 2019-10-04 | Credit Suisse Securities (Japan) Limited | Position 9,900 shares | Ratio 0.01% | ▼0.58% | Below 0.5% |
| 2026-07-06 | Morgan Stanley & Co. International plc | Position 11,061 shares | Ratio 0.01% | ▼0.93% | Below 0.5% |
| 2019-09-06 | Credit Suisse Securities (Europe) Limited | Position 0 shares | Ratio 0.00% | ▼0.74% | Closed |
Disclosure History 3266 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-13 | UBS AG | Position 506,056 shares | Ratio 0.54% | ▲0.23% | — |
| 2026-11-13 | BNP Paribas Financial Markets SNC | Position 1,340,100 shares | Ratio 1.44% | ▼0.20% | — |
| 2026-11-12 | UBS AG | Position 292,056 shares | Ratio 0.31% | ▼0.42% | Below 0.5% |
| 2026-11-12 | Nomura International plc | Position 1,341,571 shares | Ratio 1.44% | ▼0.10% | — |
| 2026-11-12 | Citigroup Global Markets Limited | Position 928,915 shares | Ratio 1.00% | ▲0.38% | — |
| 2026-11-11 | Citigroup Global Markets Limited | Position 579,815 shares | Ratio 0.62% | ▲0.06% | — |
| 2026-11-10 | UBS AG | Position 683,456 shares | Ratio 0.73% | ▼0.14% | — |
| 2026-11-10 | Nomura International plc | Position 1,431,913 shares | Ratio 1.54% | ▼0.12% | — |
| 2026-11-10 | Linden Capital L.P. | Position 2,714,819 shares | Ratio 2.93% | ▲0.14% | — |
| 2026-11-10 | BNP Paribas Financial Markets SNC | Position 1,519,500 shares | Ratio 1.64% | ▲0.09% | — |
| 2026-11-09 | Nomura International plc | Position 1,538,115 shares | Ratio 1.66% | ▼0.18% | — |
| 2026-11-09 | Linden Capital L.P. | Position 2,584,038 shares | Ratio 2.79% | ▲0.32% | — |
| 2026-11-09 | Citigroup Global Markets Limited | Position 521,215 shares | Ratio 0.56% | ▲0.10% | — |
| 2026-11-06 | Nomura International plc | Position 1,705,325 shares | Ratio 1.84% | ▲0.10% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 419,913 shares | Ratio 0.45% | ▼0.05% | Below 0.5% |
| 2026-11-06 | Linden Capital L.P. | Position 2,285,856 shares | Ratio 2.47% | ▼0.22% | — |
| 2026-11-05 | UBS AG | Position 814,962 shares | Ratio 0.87% | ▲0.13% | — |
| 2026-11-05 | Nomura International plc | Position 1,612,553 shares | Ratio 1.74% | ▲0.48% | — |
| 2026-11-05 | Linden Capital L.P. | Position 2,484,716 shares | Ratio 2.69% | ▲0.30% | — |
| 2026-11-05 | BNP Paribas Financial Markets SNC | Position 1,439,500 shares | Ratio 1.55% | ▲0.41% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 471,813 shares | Ratio 0.50% | ▼0.44% | — |
| 2026-11-04 | Nomura International plc | Position 1,175,095 shares | Ratio 1.26% | ▲0.46% | — |
| 2026-11-04 | BNP Paribas Financial Markets SNC | Position 1,056,700 shares | Ratio 1.14% | ▲0.22% | — |
| 2026-11-04 | Barclays Capital Securities Ltd | Position 871,613 shares | Ratio 0.94% | ▼0.07% | — |
| 2026-11-04 | Linden Capital L.P. | Position 2,211,541 shares | Ratio 2.39% | ▼0.26% | — |
| 2026-11-02 | GOLDMAN SACHS INTERNATIONAL | Position 300,946 shares | Ratio 0.32% | ▼0.38% | Below 0.5% |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 940,713 shares | Ratio 1.01% | ▼0.09% | — |
| 2026-11-02 | Nomura International plc | Position 749,923 shares | Ratio 0.80% | ▲0.04% | — |
| 2026-11-02 | Linden Capital L.P. | Position 2,452,619 shares | Ratio 2.65% | ▲0.40% | — |
| 2026-11-02 | Linden Capital L.P. | Position 2,082,112 shares | Ratio 2.25% | ▼0.60% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Renascience Inc.4889 | 6.87% | 3 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Fuji Pharma Co.,Ltd.4554 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| DAIICHI SANKYO COMPANY,LIMITED4568 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| KYORIN Pharmaceutical Co.,Ltd.4569 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Immuno-Biological Laboratories Co.,Ltd.4570 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nano Holdings,Inc.4571 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Carna Biosciences,Inc.4572 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |